CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change · Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Other events
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Unregistered share sale
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K/A Event Exhibits
- 4 Open-market buy 10% owner bought 3,233 shares at an average $2.69 ($8,691)
- 4 Open-market buy 10% owner bought 11,753 shares at an average $2.78 ($32,638)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 25,000 shares at $2.60 ($65,000)
- 3 Insider Initial Statement of Ownership
Page 2 of 29 · 579 filings